Table 1.

Characteristics of patients with hematological malignant disease included in the study n (%)

Characteristic	Total (n = 165)
Age (mean ± SD)	36.1 ± 23.1
Gender (M)	89 (55.6)
ALT (mean ± SD)	29.7 ± 32.8
AST (mean ± SD)	38.2 ± 49.2
Anti-HCV(+)	39 (23.6)
HBsAg(+)	13 (7.9)
Anti-HBc(+)/HBsAg(-)	54 (32.7)
Clinical characteristics
Malignant lymphoma	88 (53.3)
Hodgkin’s disease	8 (4.8)
Acute leukemia	43 (26.1)
Chronic leukemia	23 (13.9)
Multiple myeloma	3 (1.8)
Steroid containing treatment	110 (66.7)

ALT: Alanine transaminase; AST: Aspartate aminotransferase; HBsAg: Hepatitis B surface antibody; HBc: Hepatitis B virus core; M: Male.